Report Released on Chronic Diseases and Related Risk Factors
The U.S. Centers for Disease Control and Prevention released the 2021 data from the Behavioral Risk Factor Surveillance System, which are now available through CDC’s easy-to-use web-based tool.
HHS Launches a National Biotechnology and Biomanufacturing Initiative
The U.S. Department of Health and Human Services has launched a National Biotechnology and Biomanufacturing Initiative to help drive research and development.
First Once-Daily Oral Plaque Psoriasis Drug Approved by FDA
The U.S. Food and Drug Administration has approved Sotyktu (deucravacitinib), a once-daily oral pill by Bristol Myers Squibb, for adults who have plaque psoriasis (a chronic, systemic, immune-mediated disease) severe enough to make them candidates for systemic therapy and phototherapy.
Study Finds IVIG Effective for Treating Dermatomyositis
A study evaluating intravenous immune globulin for the treatment of dermatomyositis has found it significantly improved patient outcomes.
Regen BioPharma Files Patent for mRNA Cancer Vaccine
Regen BioPharma has filed a provisional patent application covering utilization of dendritic cell technologies to augment efficacy of its patented mRNA cancer immunotherapeutic vaccine.
First Malaria Vaccine Prequalified by WHO
The World Health Organization has prequalified the first malaria vaccine, RTS,S/AS01 (also known as Mosquirix), manufactured by GSK, bringing it closer to reaching millions more children at risk of malaria.
TIL Therapy Found More Effective for Metastatic Melanoma Than Current Treatments
A Phase III clinical trial has found tumor-infiltrating lymphocyte therapy, a new treatment for advanced melanoma, was more effective than ipilimumab, the lading existing therapy.
Study Finds Universal Influenza B Vaccine Induces Broad and Lasting Protection
A study by researchers at Georgia State University’s Institute of Biomedical Sciences has found a new universal flu vaccine has been found to protect against influenza B viruses that offer broad defenses against different strains and improve immune protection.
FDA Approves Humira Biosimilar to Treat Autoimmune Disorders
The U.S. Food and Drug Administration has approved Samsung Bioepis; Halima (adalimumab-bwwd) for the treatment of several autoimmune disorders, including rheumatoid arthritis, psoriatic arthritis, ulcerative colitis and Crohn’s disease.
Researchers Develop a New mRNA Vaccine to Treat Cancer
U.S. researchers have developed a new mRNA vaccine against cancer that delivers the drug directly to the lymphatic system and simulates a strong immune response.